InvestorsHub Logo
Followers 55
Posts 3732
Boards Moderated 0
Alias Born 11/12/2012

Re: None

Thursday, 11/19/2020 9:31:35 AM

Thursday, November 19, 2020 9:31:35 AM

Post# of 78
***NEWS NEWS NEWS***

Ocuphire Pharma, Inc., (NASDAQ:OCUP) a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced today the enrollment of the first patient in its MIRA-2 (NCT04620213) Phase 3 registration clinical trial evaluating the safety and efficacy of Nyxol® to reverse pharmacologically-induced mydriasis. A majority of the 12 clinical sites located around the US are open and recruiting as of this week.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCUP News